Total grant and industry support as PI or Co-I: $12,171,033

Selected active support

  1. Mechanistic role of probiotic Lactobacillus reuteri in autoimmune lupus R01-AR073240 (PI: Luo; Co-I: Allen, Cecere, Li, Reilly, Helm) NIH/NIAMS
  2. Identifying novel regulatory pathways underlying T helper 1 cell immune responses R01-AI134972 (PI: Oestreich; Co-I: Allen, Smyth, Xie) NIH/NIAID
  3. Irreversible Electroporation in Prostate Cancer (mouse, pig, and human studies) (PI: Allen; Co-I: Davalos, Verbridge)AngioDynamics Industry Support
  4. Development of Novel Porcine Models of Orthotopic Pancreatic Cancer for FUS and Histotripsy Tumor Ablation Applications (PI: Allen; Co-I: Vlaisavljevich; Coutermarsh-Ott; Lee; Clarke-Deener; Byron) Focused Ultrasound Foundation
  5. Employing Novel Porcine Models of Orthotopic Pancreatic Cancer to Evaluate Histotripsy Based Tumor Ablation Strategies R21EB028429 (PI: Allen; Co-I: Vlaisavljevich; Lee; Clarke-Deener; Coutermarsh-Ott; Byron) NIH/NIBIB
  6. A Tissue Engineering Approach to Analyzing Host-Microbe Interactions in Cancer R21CA238630 (PI: Slade, Verbridge; Co-I: Allen, Lu) NIH/NCI
  7. Non-invasive Focused Ultrasound Ablation for the Treatment of Cholangiocarcinoma Liver Tumors (PI: Vlaisavljevich; Co-I: Allen) Focused Ultrasound Foundation
  8. Nanoparticle-mediated Histotripsy (NMH) for Noninvasive and Targeted Ablation of Metastatic Breast Cancer EB027979 (PI: Vlaisavljevich; Co-I: Allen; Munson) NIH/NIBIB Trailblazer Award
  9. Targeting the peptidoglycan cell wall of Borrelia burgdorferi to diagnose and treat Lyme disease(PI: Jutras; Co-I: Allen; Helm) Steven and Alexandra Cohen Foundation
  10. Defining Mechanisms Regulated by Nonocanonical NF-κB Signaling that Modulate EoEUL1TR003015 (PI: Allen; Co-PI: McGowan) NIH/NCATS/iTHRIVE
  11. Development of an improved vaccine against Brucella abortus R03AI151494 (PI: Caswell; Co-I: Allen) NIH/NIAID
  12. Establishing Novel Murine Models for COVID-19 Research (PI: Allen; Co-I: Meng; Aguste; Weger; Duggal; Kehn-Hall) Fralin Life Sciences Institute Internal Grant
  13. A novel strategy for generating safe and effective Flavivirus vaccines R01AI153433 (PI: Aguste; Co-I: Allen; Meng; Swagata) NIH/NIAID
  14. Utilizing Novel Model Systems to Define Novel Mechanisms Controlled by the Unique Kinase NIK during Colorectal Cancer (PI: Allen; Co-I: Brown; Hagar)Foundation Support VCOM One Health

Selected completed support

  1. NLR Regulation of Gastrointestinal Inflammation and Tumorigenesis K01-DK092355 (PI: Allen) National Institutes of Health/NIDDK 
  2. Harnessing CRISPR Technology for Gene Therapy Applications JFC Seed Proposal (PI: Allen; Co-I: Davis) VT/ICTAS
  3. Anti-Tumor Microenvironment Modulation Using H-FIRE Pilot Grant (PI: Allen; Co-I: Davalos; Verbridge) VT/ICTAS
  4. Evaluating NLR Modulation of Canonical and Non-Canonical NF-kB Signaling in IBD R03-DK105975 (PI: Allen; Co-I: Cecere) NIH/NIDDK
  5. NLR Regulation of Innate Immune Responses to Respiratory Virus Infection F32-AI082895 (PI: Allen) NIH/NIAID